The cannabimimetic quinolinyl carboxylate PB-22 is an analog of JWH 018 that has been identified as a designer drug in illegal products. NPB-22 is an indazole-based derivative of PB-22 . The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
